Chapter 1. DRUG DISCOVERY INFORMATICS– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. DRUG DISCOVERY INFORMATICS– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-110 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. DRUG DISCOVERY INFORMATICS– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. DRUG DISCOVERY INFORMATICS- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. DRUG DISCOVERY INFORMATICS- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. DRUG DISCOVERY INFORMATICS– By Technique

6.1. Discovery Informatics

      6.1.1. Identification, Validation, & Assay Development Informatics

      6.1.2. Lead Generation

      6.1.3. Enzymes

      6.1.4. Other Cleanings

6.2. Development Informatics

      6.2.1. Lead Optimization

      6.2.2. FHD Preparation

      6.2.3. Phase IA

      6.2.4. Phase IB/2

Chapter 7. DRUG DISCOVERY INFORMATICS– By Mode

7.1. Outsourced

7.2. In-house

Chapter 8. DRUG DISCOVERY INFORMATICS– By Services

8.1. Sequence Analysis Platforms

8.2. Molecular Modelling

8.3. Docking

8.4. Clinical Trial Data Management

8.5. Other Services

Chapter 9. DRUG DISCOVERY INFORMATICS– By Region

9.1. North America

9.2. Europe

9.3. The Asia Pacific

9.4. Latin America

9.5. Middle-East and Africa

Chapter 10. DRUG DISCOVERY INFORMATICS – Company Profiles – (Overview, Product Portfolio, Financials, Developments)

10.1. Company 1

10.2. Company 2

10.3. Company 3

10.4. Company 4

10.5. Company 5

10.6. Company 6

10.7. Company 7

10.8. Company 8

10.9. Company 9

10.10. Company 10